412 related articles for article (PubMed ID: 27701736)
1. Molecular pathology of paediatric central nervous system tumours.
Chiang JC; Ellison DW
J Pathol; 2017 Jan; 241(2):159-172. PubMed ID: 27701736
[TBL] [Abstract][Full Text] [Related]
2. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
Wood MD; Halfpenny AM; Moore SR
Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
[TBL] [Abstract][Full Text] [Related]
3. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
Komori T
Neurol Med Chir (Tokyo); 2017 Jul; 57(7):301-311. PubMed ID: 28592714
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in embryonal tumours of the central nervous system.
Sarkar C; Deb P; Sharma MC
Childs Nerv Syst; 2005 Apr; 21(4):272-93. PubMed ID: 15682321
[TBL] [Abstract][Full Text] [Related]
5. WHO 2016 Classification of gliomas.
Wesseling P; Capper D
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):139-150. PubMed ID: 28815663
[TBL] [Abstract][Full Text] [Related]
6. Histone H3 K27 alterations in central nervous system tumours: Challenges and alternative diagnostic approaches.
Kurdi N; Mokanszki A; Mehes G; Bedekovics J
Mol Cell Probes; 2022 Dec; 66():101876. PubMed ID: 36414128
[TBL] [Abstract][Full Text] [Related]
7. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
[TBL] [Abstract][Full Text] [Related]
8. Advances in the classification and treatment of pediatric brain tumors.
Fangusaro J; Bandopadhayay P
Curr Opin Pediatr; 2021 Feb; 33(1):26-32. PubMed ID: 33278109
[TBL] [Abstract][Full Text] [Related]
9. Genomic Molecular Classification of CNS Malignancies.
Spino M; Snuderl M
Adv Anat Pathol; 2020 Jan; 27(1):44-50. PubMed ID: 31714292
[TBL] [Abstract][Full Text] [Related]
10. Utility of combining OLIG2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric- and adult-type gliomas.
Aboubakr O; Métais A; Maillard J; Hasty L; Brigot E; Berthaud C; Lacombe J; Pucelle N; Raynal J; Appay R; Varlet P; Tauziède-Espariat A
Histopathology; 2024 Apr; 84(5):893-899. PubMed ID: 38253970
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours.
Horbinski C; Berger T; Packer RJ; Wen PY
Nat Rev Neurol; 2022 Sep; 18(9):515-529. PubMed ID: 35729337
[TBL] [Abstract][Full Text] [Related]
12. In vitro karyotypic and immunophenotypic characterisation of primitive neuroectodermal tumours: similarities to malignant gliomas.
Jennings MT; Jennings DL; Ebrahim SA; Johnson MD; Turc-Carel C; Philip T; Philip I; Lapras C; Shapiro JR
Eur J Cancer; 1992; 28A(4-5):762-6. PubMed ID: 1326305
[TBL] [Abstract][Full Text] [Related]
13. Latest classification of ependymoma in the molecular era and advances in its treatment: a review.
Yamaguchi J; Ohka F; Motomura K; Saito R
Jpn J Clin Oncol; 2023 Jul; 53(8):653-663. PubMed ID: 37288489
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology of tumors of the central nervous system.
Kristensen BW; Priesterbach-Ackley LP; Petersen JK; Wesseling P
Ann Oncol; 2019 Aug; 30(8):1265-1278. PubMed ID: 31124566
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play.
Satgunaseelan L; Sy J; Shivalingam B; Sim HW; Alexander KL; Buckland ME
Pathology; 2024 Mar; 56(2):158-169. PubMed ID: 38233331
[TBL] [Abstract][Full Text] [Related]
16. CNS embryonal tumours: WHO 2016 and beyond.
Pickles JC; Hawkins C; Pietsch T; Jacques TS
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):151-162. PubMed ID: 28949028
[TBL] [Abstract][Full Text] [Related]
17. Advances in the biology and treatment of pediatric central nervous system tumors.
Vitanza NA; Cho YJ
Curr Opin Pediatr; 2016 Feb; 28(1):34-9. PubMed ID: 26709691
[TBL] [Abstract][Full Text] [Related]
18. Current therapy and the evolving molecular landscape of paediatric ependymoma.
Khatua S; Ramaswamy V; Bouffet E
Eur J Cancer; 2017 Jan; 70():34-41. PubMed ID: 27866097
[TBL] [Abstract][Full Text] [Related]
19. Practical molecular pathology and histopathology of embryonal tumors.
Phillips J; Tihan T; Fuller G
Surg Pathol Clin; 2015 Mar; 8(1):73-88. PubMed ID: 25783823
[TBL] [Abstract][Full Text] [Related]
20. Pediatric ependymomas: will molecular biology change patient management?
Grill J; Bergthold G; Ferreira C
Curr Opin Oncol; 2011 Nov; 23(6):638-42. PubMed ID: 21892086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
